Indegene Life buys US pharma services firm

The Bangalore-based pharmaceutical market services company Indegene Lifesystems has acquired a leading US pharmaceutical solutions company, Medsn Inc, signalling consolidation in the pharmaceutical services sector.

Indegene, the country's largest pharma marketing solutions company with full fledged operations in the US and Singapore, signed the takeover deal last week. The valuation of the deal is not disclosed.

Indegene is involved in providing a gamut of integrated scientific promotions, medical education and business analytics solutions to pharmaceutical and biotechnology companies worldwide.

In India, the company has offices in Delhi and Mumbai. Medsn is a pharmaceuticals solutions company in the US with more than 25 top pharmaceutical companies as its clients. By acquiring the company, Indegene would serve the global clients of Medsn.

The acquisition value could be more than the networth of Medsn Inc as the current business of the company in terms of the high profile clients could be worth more than $200 million, said an industry source.

Indegene had developed India's largest scientific healthcare network of more than 150,000 medical doctors, 50 medical institutions, 150 medical conferences, medical journals and hundreds of medical specialists from the country's leading teaching institutions.

It is a vast and credible repository of clinical data, scientific information and medical knowledge that is rapidly expanding to address the needs of the global market.

Currently, Indegene has the largest repository of medical content in India across all faculties of medicine. Coupled with its expertise in developing technology applications and educational solutions using multiple media, this repository is leveraged to provide innovative scientific solutions to the challenges encountered by clients.

The company's clientele in India includes almost every major pharmaceutical companies.